AJMC® in the Press, February 20, 2026

A feature published by The American Journal of Managed Care^® (AJMC^®) sister journal Evidence-Based Oncology^® was highlighted in an article from OncoDaily. The article, “As New Leaders Rise at SCRI, the Mission Remains: Bringing Clinical Trials Where Patients Live,” focused on the leadership transitions at Sarah Cannon Research Institute (SCRI) and what that means for its mission and priorities moving forward.

An interview published by AJMC’s sister journal Evidence-Based Oncology^® was highlighted in an article from OncoDaily. The Q&A, “Howard A. ‘Skip’ Burris III, MD: An Oncology Pioneer Reflects on Patients, Progress, and Purpose,” featured Burris reflecting on his career as it draws to a close at SCRI, including his involvement with originating the phase 1 drug development program at the research institute.

An article from The Berkshire Edge referenced an article published on AJMC.com, the website of AJMC. The article, “NIH Grant Terminations Disrupt 1 in 30 Clinical Trials, Impacting Over 74,000 Participants,” covered a research study that found that the research grant terminations at the National Institutes of Health affected 1 in 30 clinical trials, with infectious disease studies affected the most.